Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Brooklyn ImmunoTherapeutics, Inc. | CEO & President, Director | Stock Option (Right to buy) | 414K | Mar 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Mar 11, 2022 | 1 | $0 | 4/A | Mar 17, 2022 | CEO & President, Director |